Results per Page:
New drug regimen prevents both chronic and acute graft-versus-host disease
From Dr. Masumi Ueda Oshima and colleagues, Clinical Research Division
‘I can’t remember the last time I saw someone with bad gut GVHD’: BMT expert reflects on recent lifesaving successes
Fred Hutch bone marrow transplant and GVHD expert Dr. Geoffrey Hill explains how a new approach has changed the BMT landscape, where research is headed next
Novel drug regimen reduces risks of graft-versus-host disease
From the Hill Group, Translational Science and Therapeutics Division in collaboration with Alfred Health and Monash University
Fred Hutch is one of the only centers in the region offering oral medicine services
Specialized oral care for cancer patients is part of multidisciplinary care
Novel regimen greatly reduced chronic GVHD in phase 2 study at Fred Hutch
Substituting cyclophosphamide for a standard post-transplant immunosuppressant is a “gamechanger”
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer
Successful long-term outcomes for unrelated bone marrow transplants
From the Deeg Lab, Clinical Research Division
Gut microbes dictate donor T cell expansion and graft-versus-host disease risk after stem cell transplantation
From the Hill Lab, Translational Science and Therapeutics Division
Caregivers know compassion is critical; staying organized is, too
One woman shares tips on caring for a spouse going through blood cancer treatment
The interplay between intestinal microbiota and graft-versus-host disease
From the Hill Lab, Translational Science and Therapeutics Division
Blood and Marrow Transplant Reunion returns to Fred Hutch
Hundreds gather in Seattle to celebrate life, science and cancer survivorship
Outcome predictions for patients with graft-versus-host disease
From the Hematopoietic Cell Transplantation Program, Clinical Research Division
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news